Literature DB >> 14732944

[Aim, design and methods of the "Hypertension and diabetes screening and awareness" -- (HYDRA) study].

H U Wittchen1, P Krause, M Höfler, H Pfister, B Küpper, D Pittrow, P Bramlage, T Unger, A M Sharma, E Ritz, B Göke, H Lehnert, D Tschöpe, W Kirch.   

Abstract

Aim of the study is a comprehensive clinical-epidemiological description of the prevalence of arterial hypertension and diabetes among primary care patients along with an assessment of doctor's recognition rates and prescription behaviour. The paper describes methods and design of the study and provides background information on the sampling process, instruments used as well as characteristics of doctors and patients. The study is based on a nationally representative sample of 1,912 primary care doctors and 45,000 patients that attended the doctors' office on the target days. The patients were also characterized by laboratory tests. The first stage of study consisted of a comprehensive description of the doctors' characteristics in terms of psychosocial, qualification- and provider aspects as well as attitudes towards hypertension and diabetes and their management. In the second stage all patients completed a questionnaire to describe their health behaviour and attitudes as well as the treatment history and therapy. In the third stage all patients were characterized by their doctors in terms of their diagnostic status and their past and current interventions.

Entities:  

Mesh:

Year:  2003        PMID: 14732944

Source DB:  PubMed          Journal:  Fortschr Med Orig


  7 in total

1.  Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline.

Authors:  Peter Bramlage; Christiane Binz; Anselm K Gitt; Michael Krekler; Tanja Plate; Evelin Deeg; Diethelm Tschöpe
Journal:  Cardiovasc Diabetol       Date:  2010-09-16       Impact factor: 9.951

2.  Patterns of antihypertensive drug utilization in primary care.

Authors:  D Pittrow; W Kirch; P Bramlage; H Lehnert; M Höfler; T Unger; A M Sharma; H-U Wittchen
Journal:  Eur J Clin Pharmacol       Date:  2004-03-20       Impact factor: 2.953

3.  Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study.

Authors:  Roland E Schmieder; Matthias Goebel; Peter Bramlage
Journal:  Vasc Health Risk Manag       Date:  2012-03-15

4.  Polymorphisms of the insertion / deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data.

Authors:  Adrian Mondry; Marie Loh; Pengbo Liu; Ai-Ling Zhu; Mato Nagel
Journal:  BMC Nephrol       Date:  2005-01-11       Impact factor: 2.388

5.  Prevalence of nephropathy in the German diabetes population-Is early referral to nephrological care a realistic demand today?

Authors:  Wolfgang Pommer
Journal:  NDT Plus       Date:  2008-10

6.  Changes in the prevalence, treatment and control of hypertension in Germany? A clinical-epidemiological study of 50.000 primary care patients.

Authors:  Alexander Michael Labeit; Jens Klotsche; Lars Pieper; David Pittrow; Franziska Einsle; Günter Karl Stalla; Hendrik Lehnert; Sigmund Silber; Andreas Michael Zeiher; Winfried März; Martin Wehling; Hans-Ulrich Wittchen
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

7.  Prevalence of obesity in primary care using different anthropometric measures--results of the German Metabolic and Cardiovascular Risk Project (GEMCAS).

Authors:  Hans Hauner; Peter Bramlage; Christian Lösch; Elisabeth Steinhagen-Thiessen; Heribert Schunkert; Jürgen Wasem; Karl-Heinz Jöckel; Susanne Moebus
Journal:  BMC Public Health       Date:  2008-08-11       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.